Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) announced that, pursuant to a confidential partial settlement agreement, it has dismissed two patent infringement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE